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JO PROGESTINS REGUl ,E 
MENSTRUAL CYCLE: 
G. C. NABORS, M.D.
What is the medical evidence that 
progestins can "regulate" menstrual
cycles? The inference has been
that by using a prescribed regimen
of_ trea:ment, irregular menstruators
will miraculously menstruate every 
28 days thereafter. The whole idea
has been misconstrued by the gen -
�ral public and the common belief
is that the moral licitness of the use
of progestins to regulate menses
means taking them indefinitely. An 
even more ridiculous misconception
by some is shown by the patient
who comes to the gynecologist and
says that her confessor has "granted 
her permission" to use the progestins
for a period of 2 years in order to 
regulate her menses It is of 
k 
· course,
n�t
. 
nown if this is the advice of a
m1�mformed priest, or the interpre­
tatwn th� P;nitent wished to put
upon a pnest s a_dvice. Be that as it 
may, th� object of this paper is not
to condemn, but to emphasize the 
fact that there is a very widespread
an_d absurd confusion existing amon 
priests, pa:ients and physicians. Th!
�econd _ob1ect is to examine the med-
teal _evidence upon which any such 
b
med1cal and theological opinion was
ased. 
First of all, it is going to be diffi­
cult for us to agree about h . 
. 1 
w o 1s an
irregu ar menstruator Most 
___ 
· gyne-
Dr. Nabors, a Diplomate of the Am 
Board of Ob . 
encan 
stetncs and Gynecology . . 
practice in Dallas, Texas. 
' is m
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cologists' exi
woman has 
25 to 35 day 
tion should r
unusual. Fm
that every v. 
much and if 5
because she h
rate observer 
ords. When r 
shown in one 
tistically signit
of the time die
the 28th day
who would ai
to menstruate. 
that it is withi.
treatment to s 
does menstrua
to heed this s i 
1 ce is that every
·s that vary from
d that such varia·
·ven be considered 
;·more, it is a fact 
nn does vary this 
Jenies it, it is only
not been an accu·
kept accurate rec·
·ds are kept, as was 
' nt large and sta-
1t seriesl only 15%
enstruation fall on
the cycle. Those
that it is normal 
· ry 28 days and 
he bounds of good
hat every woman 
�very 28 days need
:ficant fact. 
Very often t; , woman who 
con­
fronts the gyfo O logist with a p
lea 
for a prescripti, ,.1 for progestin
s to 
regulate her will answer, . 
when 
·asked, that she is so irregular 
that
she is unable 10 use rhythm, 
that 
her cycles vary from 27 to 32 
days. 
This borders on the ridiculo
us, to
be called irregular. Be that 
as !t
may, it is true that there ar
e van· 
ants of the physiological wh
o are
going to have cycles longer th
an_3S
days. For the sake of elim
inat!Ilg
argument and in the int
erest of
evaluating our subject, let u
s arbi-
1Marshall," John, The Infertile Period,
Helicon Press, 1964 
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g agreed then that cycles
last longer than 40 days repre­
abnormality, let us try to cate­
fllle it diagnostically. We might 
• to this condition as oligom
en­
ea or secondary amenorrhea. 
llgomenorrhea is the same as 
•odic" secondary amenorrh
ea. 
1'erefore, the difference between 
lgomenorrhea and secondary
llmorrhea is semantic. 
Before the confosion wrought by
progestins, gynecologists were
alt inclined to treat such states of
IIIIOndary amenorrhea. In 
treating
subject, Brown and Kistner
2 
ee summed up the general gyne­
iillogic opinion by saying: 
Kupperman and Epstein
ss, I',oland, Smith
and Romney12, Roland39 and Go
\d40 havl 
also used Enovid successfully in
 the treat­
ment of secondary amenorrhea
. In both
types of amenorrhea, it is know
n that a
course of Enovid treatment m
ay be fol­
loll'ed by resumption of normal
 menstrua­
tion. Brown and Kistner
41 state that
Enovid may be similarly us
ed for the 
management of oligomenorrhea 
and hypo-
menorrhea. 
Let us go first to the 
evidence
allegedly produced by Br
own and
Kistner, reference 41 abo
ve. This
is actually what they sa
y in the
reference: 
t;::ly, in the absence of prov
ed organic
amenorrhea as a clinical symptom
lmlDts treatment only as it relates to dis­
flllied emotional states or to infertility.·
If adequate estrogen prim
ing is present,
cyclic bleeding from a secr
etory endome­
trium may be obtained by 
the adminis- -
tration of 10 - 20 mg. of 
norethindrone 
or norethnodrel for 20 co
nsecutive days. 
Within 2 - 4 days after stop
ping the medi­
cation a bleeding episode l
asting from 4 to 
5 days will occur. If adequ
ate estrogen 
priming has not been present 
bleeding will
not occur and in such cases 
the prelim­
inary use of an estrogen is usu
ally necessary
for an effective response. It 
i s suggested 
that artificial cycles of the ty
pe be carried
out for 3 - 4 months. Not infr
equently, for
reasons unknown, spontane
ous menstrua-
�ps
 the woman who considers
�larity a hazard to her
fllCtice of rhythm has a· disturbed
anotlooal state, but this is not likely
ID have been what these authors
lant 
12Roland, M.; Smith, J. J., and 
Romney, S.
L.: New Synthetic Progestational Com­pound in Infertility, Int. J. Fertil. 5:8-18
(Jan.-March) 1960 Let us not even argue the point
• to whether such treatment of sec­
� amenorrhea is warran
ted. 
US assume that it is; then what
ta
b medical evidence that proges­
• 
will treat it satisfactorily? If
_: to the literature of the G. D.
._ __ ,, 
Company, manufacturers of
� fi d 
_ 
we n the following: 
� .. _&. Kistner, Essential of Human
ion, Oxford Press, New York,
._, p. 155 'i!u, Searle & Co., Physiciani Product
1183 
e No. 67, Chicago 80, Illinois,
38Kupperman, H. S., and 
Epstein, J. A.: 
Proceedings of a Symposium on 19-NorProgestational Steroids: Gonadotropic­Inhibiting and Uterotropic Effects ofEnouid, Chicago, Searle Research Labor-
atories, 1957, pp. 32-45 
39Roland, M.: Proceedings of a Symposium 
on 19-Nor Progestational Steroids; Ob­servations on Patients with AnouulatoryCycles and Amenorrhea When Enouidis Administered, Chicago, Searle Research
Laboratories, 1957, pp. 51-66 
40Gold, J. J.: Proceedings of a Symposium on 19-Nor Progestational Steroids: Clin­
ical Experience with Enouid, Chicago,
Searle Research Laborato
ries, 1957, pp.
86-96 
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tio� occurs a,, · the progestogen-induced 
penods have f;. , n discontinued. 
· Let us notice carefully just what
this says. First of all they present 
no data or  factual evidence that 
their claim is true. We do not wish 
to doubt the observations of these 
outstanding investigators. In the 
first place they never made the 
claims that the Searle brochure in -
ferred t?ey had. The other thing 
they said was that their r ecom -
mendation was to use it for 3 - 4 
m�nths. Based on even this quasi­
ev'.den�e, one cannot then justify 
usmg It for 2 years in order to 
"regulate" the cycles. 
The principle of the theory of this 
treat�ent is well known to gyne­
cologists and was first described in 
relation to the use of estrogen 
and progesterone and is commonly 
referred to as the "rebound phe­
nomenon." 
If we now go back again to the 
Brown and Kistner reference 41 
above, we see that they have this 
to say further : 
Endocrine preparations are also employed 
to remove gonadotropic stimulation of the 
ovaries. The rationale of this treatment 
utilizes the observation that estrogenic sub-
stances, administered in large doses, block 
the ad�nohypophyseal release of the gona­
dotropms. Existing evidence suggests that 
the gonadotropic hormones are accumu­
lated or stored in higher concentrations in 
the pi�uitary gland during this period of  
endocrine therapy. Cessation of the treat­
ment, t�eoretically at least, releases the 
estrogemc blockage and results in a sudden 
burst of gonadotropic activity. The desired 
�£feet of _this so-called rebound phenomenon 
1s to stimulate the ovaries sufficiently to 
promote ovulation and normal menstrual 
function. Unfortunately, the results are
disappointingly poor. [italics mine] 
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Let us exr at this time just 
what the cl of the rebound 
phenomenon This work is ex-
plained by ? · in a number of 
publications. essence the work 
was based ;iving 80 sterility 
patients incr, · s doses of diethyl·
stilbesterol c for three months 
and increasir ;Ses of progesterone 
during the : time. Thirteen of 
the 80 w01 became pregnant 
within 4 mm of treatment. When 
one is deali · vi th sterility prob· 
lems these . lts are astounding. 
· Please note this point that the 
patients unc.· discussion in this 
work were 'lity problems and 
not hyper-fe 'Y problems. Even 
so, the prh e of the rebound 
phenomenon not be ignored and 
it is only r 1ctively reasonable 
that such a •ound phenomenon
may result •hose patients who
are very ir. Jar ovulators and 
menstrua tor -t should be re-
emphasized, ,wever, that such 
treatment is ,,ified for only 3-4 
months. No �'dical evidence has 
ever suggestc � years or indefinite 
time spans, r, · .. n ything more than 
3 - 4 months. 
. Let us nov ,eturn to the refer-
. ence 3 in pat. ,aph 7 which states. 
"Kupperman : 1d Epstein, Roland, 
Smith and l' ,,nney, Roland and 
Gold have als., used Enovid success· 
fully in the tn'atment of secondary 
amenorrhea." ff one scrutinizes these 
articles, he I:n<ls that what these 
investigators cli covered was that 
4Rock, J._; Garcia, _C.-�., and 
Pinc1·Ju�
Synthetic Proge;,ins m the Norena 
Gman Menstrual Cycle, in Pincus. 
(editor): Recent Progress in �or;: Research New York Academic 
Inc., vol.' 13, 1957, pp. 323-339 
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who have amenorrhea, if 
Enovid, will bleed when it is 
wn. There is no evidence 
that following cessation of 
, menstrual periods are any 
regular than previously. As a 
of fact the reference to the 
of Roland reveals the follow­
striking conclusion in his own 
withdrawal bleeding be­
two and three days after cessation 
mlication. The bleeding in most in­
wu scanty; - in several this scant 
It continued for eight to ten days. The 
ovulatory patients had heavy bleeding 
Illa clots but it was of normal duration .. 
�tion during the cycles ,vhich fol­
lflllll the treated ones reverted back to .... 
One assumes that when ·he says 
le, reverted back to "normal," he 
lllew to what they had been pre� 
-1y, since they were c1.ealing
with ovulatory women. One can 
liudly deny that women with 
�-fertility are also ovulatory 
llllnen. As we understand this, then 
The above investigat ,ns of Ro­
land and perhaps others apparently 
led the G. D. Searle Company to 
print in their  brochure (3) on page 
20, the following: "Ovulation in the 
fm t cycle after treatment may be 
dclaved for three to  five days or  
evc1; longer; subsequent cycles will 
usually revert to the duration pre­
viously typical of the individual 
patient." 
To sum up, the most liberal of 
medical evidence would only support 
the use of progestins for a period of 
means that using progestins for a 
JISlod of several months allows a 
l'lllllan to bleed at predictable inter-
1111 IS long as she is being medi­
Clled, but following withdrawal of 
'-tment, one can expect her pattern 
1D lie uninfluenced. 
3 - 4 months in conditions of irregu­
lar menstruation. Even those who 
believe that this has merit admit 
that the results are disappointingly 
poor. These cases were women who 
had gone f or several months with­
out menstruating. Actually there 
has been no work published, to the 
knowledge of this author, which 
even attempts to show that the very 
fertile woman who menstruates on 
cycles varying from 26 to 4.0 days 
can cause these habits to change by 
the use of progestins. There is even 
evidence to support that this does 
not occur: the quotation of Roland 
above and the admission of the 
G.D. Searle Company who make it 
clear that "subsequent cycles will 
usually revert to the duration pre­
viously typical of the individual 
patient." 
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